left-caret

Advice for Businesses in Dealing with the Expanding Coronavirus Events

COVID-19 Webinar: Public Company Disclosures

April 03, 2020

PH COVID-19 Task Force

The spread of the coronavirus continues to spread globally, public companies are facing a myriad of questions and uncertainty as they begin to prepare first quarter reports. In our webinar we discussed liability considerations and advice on disclosure considerations as we navigate these uncertain times. By early March, companies were taking different approaches. We saw that companies that have significant operations or supply chains involving China, or that are particularly vulnerable to the impact of COVID-19, were including more tailored disclosures. Additionally, they began including COVID-19-related disclosures in their MD&A that were customized for their business and industry. We discussed these and other disclosure trends and provided practical guidance around the decision making process about what to disclose.

Click here to view the slide presentation.

FEATURED SPEAKERS

111121

Kevin P. Broughel
Partner, Securities Litigation

116914

John Nowak
Partner, Investigations & White Collar Defense

101463

Teri E. O'Brien
Partner, Securities & Capital Markets

120588

James Shea
Of Counsel, Securities & Capital Markets